Form 4: Anterix Director Acquires 7,767 Restricted Shares

Anterix Inc. Director Mark Fleischhauer was granted 7,767 shares of restricted common stock as compensation, vesting by August 2026.

Summary

• Mark Fleischhauer, a Director of Anterix Inc. (ATEX), acquired 7,767 shares of common stock.
• The acquisition occurred on August 5, 2025, and was a grant of restricted stock.
• The shares were acquired at a price of $0, indicating they are compensation for services as a non-employee director.
• Following this transaction, Mr. Fleischhauer beneficially owns a total of 16,269 shares of Anterix common stock.
• The restricted stock vests in full on the earlier of August 5, 2026, or the Issuer's next annual stockholder meeting.
• Vesting is subject to automatic adjustment to the next trading day if the original vesting date falls on a closed trading day under the Issuer's Insider Trading Policy.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is a positive sign of aligning management interests with shareholders. It does not contain any negative or unexpected information.

Positives

• The grant of restricted stock to a director aligns their interests with shareholders, promoting long-term commitment to the company's performance.
• Compensating non-employee directors through equity grants is a common and often preferred practice in corporate governance, reinforcing a performance-based culture.

Negatives

• No direct negatives are identified in this specific Form 4 filing, as it reports a standard compensation event.

Risks

• No specific new risks are introduced or highlighted by this Form 4 filing beyond the general market risks inherent in holding equity.

Future Outlook

The restricted stock granted to Director Mark Fleischhauer is set to vest on the earlier of August 5, 2026, or the Issuer's next annual stockholder meeting, indicating a future milestone for the shares.

Industry Context

This transaction is a routine disclosure of insider stock ownership changes, specifically an equity grant as compensation. It reflects standard corporate governance practices for compensating non-employee directors in the technology or telecommunications sector, where Anterix operates.

Comparison to Industry Standards

• Granting restricted stock to non-employee directors is a common practice across publicly traded companies, including those in the telecommunications and critical infrastructure sectors.
• The vesting schedule (one year or next annual meeting) is typical for director equity compensation, aiming to retain directors and align their interests with long-term company performance.
• The $0 price for restricted stock grants is standard, as it represents compensation rather than a purchase.

Corporate Governance

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially encouraging decisions that benefit long-term stock value. It also represents a minor dilution from new share issuance upon vesting, though this is standard for equity compensation.

Next Steps

• The restricted stock granted to Mr. Fleischhauer will vest in full on the earlier of August 5, 2026, or the Issuer's next annual stockholder meeting.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to an existing non-employee director as part of their compensation. Such transactions are standard practice and do not typically provide new material information that would warrant a change in investment recommendation. It reinforces alignment of director interests with shareholders but does not indicate significant operational or financial shifts.

Keywords

Anterix Inc., ATEX, Form 4, Insider Trading, Restricted Stock, Director Compensation, Equity Grant, Mark Fleischhauer